Discontinuing immunotherapy: Is the infusion bag half empty or half full?November 23, 2022Lung CancerCNS/Brain CancerGastrointestinal CancerGenitourinary CancerGynecologic CancerHead & Neck/Thyroid CancersImmuno-oncology
How AI is, or will soon be, relevant in radiation oncologyNovember 13, 2022Lung CancerBreast CancerGastrointestinal CancerGenitourinary CancerGynecologic CancerHead & Neck/Thyroid CancersMetastatic Breast Cancer
Chronic stress, especially race related, may hasten cancer deathNovember 13, 2022Diversity in MedicineGastrointestinal CancerGenitourinary CancerGynecologic CancerHead & Neck/Thyroid CancersLung CancerMelanoma
Third COVID booster benefits cancer patientsNovember 12, 2022COVID-19 UpdatesBreast CancerGastrointestinal CancerGynecologic CancerGenitourinary CancerHead & Neck/Thyroid CancersLung Cancer
Findings may be practice changing for early breast cancer patientsOctober 31, 2022Metastatic Breast CancerBreast Cancer
Study affirms better breast cancer outcomes when chemo comes firstOctober 26, 2022Metastatic Breast CancerBreast Cancer
Cancer as a full contact sportOctober 3, 2022Patient & Survivor CarePractice ManagementRenal Cell CarcinomaMetastatic Breast CancerMixed TopicsMelanomaLung Cancer
Cost paramount when choosing metastatic breast cancer treatmentSeptember 30, 2022Metastatic Breast CancerBreast Cancer
FDA OKs selpercatinib for adults with RET-fusion+ solid tumorsSeptember 23, 2022Lung CancerHead & Neck/Thyroid CancersGastrointestinal CancerMetastatic Breast Cancer
High BMI linked to better survival for cancer patients treated with ICI, but for men onlySeptember 22, 2022Lung CancerBreast CancerGastrointestinal CancerGynecologic CancerGenitourinary CancerHead & Neck/Thyroid CancersMetastatic Breast Cancer
A farewell to arms? Drug approvals based on single-arm trials can be flawedSeptember 19, 2022Gastrointestinal CancerPractice ManagementMixed TopicsBreast CancerCNS/Brain CancerGenitourinary CancerGynecologic Cancer
Time to cancer diagnoses in U.S. averages 5 monthsSeptember 15, 2022Breast CancerCNS/Brain CancerGastrointestinal CancerGenitourinary CancerGynecologic CancerHead & Neck/Thyroid CancersLung Cancer
Tumor-bed radiotherapy boost reduces DCIS recurrence riskAugust 29, 2022Metastatic Breast CancerBreast Cancer
Getting cancer research on track again may require a ‘behemoth’ effortAugust 15, 2022Mixed TopicsBreast CancerCNS/Brain CancerGastrointestinal CancerGenitourinary CancerGynecologic CancerHead & Neck/Thyroid Cancers
FDA approves trastuzumab-deruxtecan for HER2-low breast cancerAugust 5, 2022Metastatic Breast CancerBreast Cancer
